Shoupeng Lai

Title: Shoupeng Lai: Innovator in Adenoviral Vector Production

Introduction

Shoupeng Lai is a notable inventor based in Burtonsville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production of adenoviral vectors. His innovative methods have the potential to enhance the efficiency of vector stock production, which is crucial for various applications in gene therapy and vaccine development.

Latest Patents

Shoupeng Lai holds a patent for a method of producing adenoviral vector stocks. The patent outlines a process that involves culturing cells permissive for the growth of adenoviral vectors in a specific medium. The method includes perfusing fresh medium through the culture, allowing for optimal cell density, and subsequently contacting the culture with adenoviral vectors to facilitate infection. This innovative approach aims to improve the yield and quality of adenoviral vector stocks.

Career Highlights

Shoupeng Lai is currently associated with Genvec, Inc., where he applies his expertise in biotechnology. His work focuses on developing advanced methods for vector production, which are essential for the advancement of gene therapy techniques. His contributions have been instrumental in pushing the boundaries of what is possible in the field of genetic engineering.

Collaborations

Shoupeng Lai collaborates with Lee-Cheng Liu, a fellow innovator in the field. Together, they work on projects that aim to enhance the production and application of adenoviral vectors, contributing to the broader scientific community.

Conclusion

Shoupeng Lai's innovative work in the production of adenoviral vectors represents a significant advancement in biotechnology. His patent and ongoing research efforts are paving the way for future developments in gene therapy and related fields.